Scholarly publications

2022

Pazzagli L, Liang D, Andersen M, Linder M, Khan AR, Sessa M. Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources. Sci Rep. 2022 Apr 15;12(1):6245. doi: 10.1038/s41598-022-10144-9. PMID: 35428827; PMCID: PMC9012860.

Liang D, Sessa M. Post-marketing safety surveillance of erenumab: new insight from Eudravigilance. Expert Opin Drug Saf. 2022 Mar 2. doi: 10.1080/14740338.2022.2049231. Epub ahead of print. PMID: 35236231. 

2021

Liang D, Gardella E, Kragholm K, Polcwiartek C, Sessa M. The Relationship Between Valproate and Lamotrigine/Levetiracetam Use and Prognosis in Patients With Epilepsy and Heart Failure: A Danish Register-Based Study. J Card Fail. 2021 Aug 24:S1071-9164(21)00339-0. doi: 10.1016/j.cardfail.2021.07.020. PMID: 34438055.

Sessa M, Liang D, Khan AR, Kulahci M, Andersen M. Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 2-Comparison of the Performance of Artificial Intelligence and Traditional Pharmacoepidemiological Techniques. Front Pharmacol. 2021 Jan 14;11:568659. doi: 10.3389/fphar.2020.568659. PMID: 33519433; PMCID: PMC7841344.

2020

Pellesi L, De Icco R, Alawie HY, Andersen M, Liang D, Amirguliyev S, Al-Karagholi MA, Amin FM, Sessa M. A systematic review, meta-analysis and meta-regression evaluating the adverse reactions to erenumab in the preventive treatment of migraine. Expert Opin Drug Saf. 2021 Apr;20(4):467-474. doi: 10.1080/14740338.2021.1866537. Epub 2020 Dec 29. PMID: 33337920.

Sessa M, Khan AR, Liang D, Andersen M, Kulahci M. Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 1-Overview of Knowledge Discovery Techniques in Artificial Intelligence. Front Pharmacol. 2020 Jul 16;11:1028. doi: 10.3389/fphar.2020.01028. PMID: 32765261; PMCID: PMC7378532.